Shannon Manzi, PharmD
Director of Safety & Quality, Department of Pharmacy; Applied Informatics Faculty, Computational Health Informatics Program (CHIP)
Assistant Professor of Pediatrics, Harvard Medical School
Image
Shannon Manzi, PharmD
Director of Safety & Quality, Department of Pharmacy; Applied Informatics Faculty, Computational Health Informatics Program (CHIP)
Assistant Professor of Pediatrics, Harvard Medical School
Medical Services
Languages
English
Education
Undergraduate School
University of Rhode Island
1996
Kingston
RI
Professional History
I am a clinical pharmacist and have practiced pediatric pharmacy for more than 20 years, currently serving as the Director of the Clinical Pharmacogenomics Service and the Manager for ED and ICU Pharmacy Services.
Dr. Manzi serves as an expert for the Pharmacy program for Boston Children's Hospital Precision Medicine Service. For more information about the Precision Medicine Service please visit bostonchildrens.org/precisionmed.
Approach to Care
Patient safety is the ultimate driver behind everything we do, including making medication use safer in children by personalizing therapy and ensuring robust processes exist for medication preparation and delivery.
Publications
Comparison of 2-Bag Method With Serial Bag Method for Treatment of Pediatric Diabetic Ketoacidosis. View Abstract
Recommendations for the Management of Initial and Refractory Pediatric Status Dystonicus. View Abstract
A Life Less Ordinary. View Abstract
Dispensing Medications at the Hospital Upon Discharge From an Emergency Department. View Abstract
Experience of pharmacy involvement in a disaster simulation exercise within a pediatric hospital emergency department: A pilot project. View Abstract
Fluvoxamine for the treatment of COVID-19. View Abstract
Weaning Dexmedetomidine in Non-ICU Areas: An Implementation Effort. View Abstract
Patients dispensed medications with actionable pharmacogenomic biomarkers: rates and characteristics. View Abstract
Adverse drug event presentation and tracking (ADEPT): semiautomated, high throughput pharmacovigilance using real-world data. View Abstract
Benzalkonium Chloride in Albuterol Solutions: Time for a Change? View Abstract
Off-label use of prescription analgesics among hospitalized children in the United States. View Abstract
Adverse drug event rates in pediatric pulmonary hypertension: a comparison of real-world data sources. View Abstract
Recurrent SLC1A2 variants cause epilepsy via a dominant negative mechanism. View Abstract
Whole-Exome Sequencing Enables a Precision Medicine Approach for Kidney Transplant Recipients. View Abstract
Pharmacist Outpatient Prescription Review in the Emergency Department: A Pediatric Tertiary Hospital Experience. View Abstract
HLA-A*31:01 and Oxcarbazepine-Induced DRESS in a Patient With Seizures and Complete DCX Deletion. View Abstract
Initial Pain Management in Pediatric Acute Pancreatitis: Opioid Versus Non-opioid. View Abstract
Practical considerations for implementing genomic information resources. Experiences from eMERGE and CSER. View Abstract
Creating a scalable clinical pharmacogenomics service with automated interpretation and medical record result integration - experience from a pediatric tertiary care facility. View Abstract
Lacerations and Embedded Needles Caused by Epinephrine Autoinjector Use in Children. View Abstract
Practical considerations in genomic decision support: The eMERGE experience. View Abstract
Electronic medication reconciliation and medication errors. View Abstract
13-year-old girl with recurrent, episodic, persistent vomiting: out of the pot and into the fire. View Abstract
Utility of a dedicated pediatric cardiac anticoagulation program: the Boston Children's Hospital experience. View Abstract
Misinterpretation of TPMT by a DTC genetic testing company. View Abstract
Pharmacointeraction network models predict unknown drug-drug interactions. View Abstract
Development of a scalable pharmacogenomic clinical decision support service. View Abstract
Dispensing medications at the hospital upon discharge from an emergency department. View Abstract
Predicting adverse drug events using pharmacological network models. View Abstract
Response to challenges and lessons learned from Hurricanes Katrina and Rita: a national perspective. View Abstract
Patients providing the answers: narrowing the gap in data quality for emergency care. View Abstract
Getting the data right: information accuracy in pediatric emergency medicine. View Abstract
FEMA's organized response with a pediatric subspecialty team: the National Disaster Medical System response: a pediatric perspective. View Abstract
Preprocedural fasting state and adverse events in children undergoing procedural sedation and analgesia in a pediatric emergency department. View Abstract
Methylphenidate produces a false-positive urine amphetamine screen. View Abstract
Locations